Chugai Pharmaceutical Co. Ltd. provided dividend guidance for the second quarter ending June 30, 2015. The company forecasts a dividend of ¥26.00 per share for the second quarter of fiscal 2015.

For the year ending December 2015, the company forecasts year-end dividend of ¥26.00 per share.

The company announced unaudited consolidated earnings results for the year ended December 31, 2014. For the year, the company reported revenues were JPY 461,109 million against JPY 423,652 million a year ago. Operating profit was JPY 75,859 million against JPY 78,738 million a year ago. Profit before taxes was JPY 76,164 million against JPY 76,944 million a year ago. Net income was JPY 52,077 million or JPY 93.38 diluted per share against JPY 51,886 million or JPY 93.35 diluted per share a year ago. Net income attributable to Chugai shareholders was JPY 50,980 million against JPY 50,895 million a year ago. Profit before taxes was JPY 76,164 million against JPY 76,944 million a year ago. Cash flows from operating activities were JPY 37,034 million against JPY 53,521 million a year ago. Purchase of property, plant and equipment was JPY 16,232 million against JPY 11,287 million a year ago. Purchase of intangible assets was JPY 2,935 million against JPY 3,377 million a year ago.

For the year ending December 31, 2015, the company expects revenues of JPY 486,500 million, core operating profit of JPY 85,000 million and core earnings per share of JPY 104.42.